Beacon NewsFlashes – September 9, 2013 The Myeloma Beacon For more information, please refer to the study in the journal Bone Marrow Transplantation (abstract). CD44 May Be A Good Indicator Of Revlimid Resistance In Myeloma – Findings from a recent preclinical study conducted at M. D. Anderson indicate that ... |
